PPARG and steatosis: Increased expression of FASN, ACC, and PPARG was also observed in HepG2 cells transfected with miR-483 (Figure 4E), suggesting that miR-483 modulates the expression of steatosis/lipogenesis markers that leads to inhibition of cell steatosis.